Zivo Bioscience, Inc. Common Stock
ZIVO
ZIVO was delisted on the 24th of November, 2023.
3 hedge funds and large institutions have $43.2K invested in Zivo Bioscience, Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
26% less capital invested
Capital invested by funds: $58.3K → $43.2K (-$15.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KBFS
Kohmann Bosshard Financial Services
Fairlawn,
Ohio
|
+$4.35K |
Top Sellers
ZIVO Hedge Fund Activity: Q4 2025 in Review
3 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q4 2025, worth a combined $43.2K — down 26% from $58.3K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ZIVO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Kohmann Bosshard Financial Services, opening a new position worth an estimated $4.35K.
- 3 institutional investors held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q4 2025, up from 2 in Q3 2025.
- Funds reported $43.2K of Zivo Bioscience, Inc. Common Stock stock for Q4 2025, down 26% quarter-over-quarter.
- 1 fund opened new Zivo Bioscience, Inc. Common Stock positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest Zivo Bioscience, Inc. Common Stock buyer in Q4 2025 was Kohmann Bosshard Financial Services, an estimated $4.35K added.
Based on aggregated 13F filings for Q4 2025.